Erasmus Mundus Joint Doctorate Program
Erasmus Mundus Joint Doctorate Programme is a cooperation and mobility programme funded by the Education, Culture and Audiovisual Executive Agency (EACEA) of the European Commission in the field of higher education for:
- the enhancement of quality in European higher education;
- the promotion of the European Union as a centre of excellence in learning around the world;
- the promotion of intercultural understanding through cooperation with third countries as well as for the development of third countries in the field of higher education.
The programme enables PhD students to get a double degree from two different partner institutes of the consortium (see below for partners involved in the project).
The studies conducted within the current programme will contribute to improved access to care and prevention; quality health services to ensure better health outcomes; innovative care constellations that build on patient/community engagement as well as public-private partnerships; and re-orientation of the current global health emphasis on infectious diseases by incorporating the challenges of non-communicable diseases and ageing. Integrated and effective global health solutions will be realized through synergistic, transdisciplinary and evidence-based research.
AIGHD is currently hosting four PhD students within this program:
- Willy Ssengooba from Uganda completed his PhD (2013-2016) titled: “Consequences of Mycobacterium tuberculosis genetic diversity in the context of HIV co-infection for laboratory diagnosis of tuberculosis in Africa”
- Seth Inzaule from Kenya is completing his PhD from 2014-2017. His PhD is titled: “Towards successful long-term antiretroviral treatment in sub-Saharan Africa: outcomes, determinants and diagnostics”
- Alberto Lopez Garcia-Basteiro from Spain is undertaking his PhD from 2015-2018. His PhD is titled: “Towards improving TB mortality estimates in Mozambique”
- Gertrude Nsorma Nyaaba from Ghana is undertaking her PhD from 2015 – 2018. Her PhD is titled: “Improving hypertension control among sub-Saharan Africans: the case of Ghanaians”
Consequences of Mycobacterium tuberculosis genetic diversity in the context of HIV co-infection for laboratory diagnosis of tuberculosis in Africa.
Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients.
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.
Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
Clinical Utility of a Novel Molecular Assay in Various Combination Strategies with Existing Methods for Diagnosis of HIV-Related Tuberculosis in Uganda.
Poor tuberculosis treatment outcomes in Southern Mozambique (2011-2012).
Design of tuberculosis vaccine trials under financial constraints.
Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients.
The role of Xpert MTB/RIF in diagnosing pulmonary tuberculosis in post-mortem tissues.
Low pediatric Case Detection Rate in Southern Mozambique.
AIGHD Research Lead
Prof. Frank Cobelens
Prof. Tobias Rinke de Wit
VU University Amsterdam (Netherlands)
University of Amsterdam (Netherlands)
Academic Medical Centre at the University of Amsterdam (Netherlands)
Université de Bordeaux (France)
Institute of Tropical Medicine Antwerp (Belgium)
University of Barcelona Institute for Global Health (Spain)
Marloes Nijboer (firstname.lastname@example.org)
Education, Culture and Audiovisual Executive Agency (EACEA) of the European Commission